The palmitoyl groups of lung surfactant protein C reduce unfolding into a fibrillogenic intermediate

Journal of Molecular Biology

Volumn 310, Issue 4, 2001, Pages 937-950

  Gustafsson, Magnus ^a   Griffiths, William J ^a   Furusjö, Erik ^b   Johansson, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Amyloid fibrils; Lipid associated peptides; Protein S palmitoylation; Pulmonary surfactant; SP C

Indexed keywords

AMYLOID; LUNG SURFACTANT; PROTEIN C;

ALPHA HELIX; ANIMAL TISSUE; ARTICLE; BETA SHEET; CONTROLLED STUDY; DESORPTION; LUNG ALVEOLUS; LUNG PARENCHYMA; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEINOSIS; SWINE;

EID: 0035919776     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.4810     Document Type: Article

References (50)

1. The pulmonary surfactant system: Biochemical and clinical aspects
2. Structure and properties of surfactant protein B
3. Synthesis, processing and secretion of surfactant proteins B and C
4. Regulation of surfactant protein gene transcription
5. The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich α-helix
6. Structure and properties of surfactant protein C
7. Hydrophobic surfactant-associated polypeptides: SPC is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups
8. Pulmonary surfactant-associated polypeptide C in a mixed organic solvent transforms from a monomeric α-helical state into insoluble β-sheet aggregates
9. The effect of environment on the stability of an integral membrane helix: Molecular dynamics simulations of surfactant protein C in chloroform, methanol and water
10. Amyloid fibril formation by pulmonary surfactant protein C
11. Alternative conformations of amyloidogenic proteins govern their behavior
12. Amyloid fibrillogenesis: Themes and variations
13. Protein misfolding, evolution and disease
14. Amyloid deposits and amyloidosis: The beta-fibrilloses (second of two parts)
15. Watching amyloid fibrils grow by time-lapse atomic force microscopy
16. Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease
17. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing
18. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro
19. The molecular basis of amyloidosis
20. Common core structure of amyloid fibrils by synchrotron X-ray diffraction
21. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
22. Amyloid fibrils from muscle myoglobin. Even an ordinary globular protein can assume a rogue guise if conditions are right
23. Designing conditions for in vitro formation of amyloid protofilaments and fibrils
24. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
25. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: Evidence from electrospray mass spectrometry
26. Translating cell biology into therapeutic advances in Alzheimer's disease
27. Signalling functions of protein palmitoylation
28. Fatty acylation of proteins: New insights into membrane targeting of myristoylated and palmitoylated proteins
29. Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C
30. Structure and orientation of the surfactant-associated protein C in a lipid bilayer
31. Acylation of pulmonary surfactant protein-C is required for its optimal surface active interactions with phospholipids
32. New developments in microscale separations and mass spectrometry for biomonitoring: Capillary electrophoresis and electrospray ionization mass spectrometry
33. Electrospray ionization mass spectrometry for the study of non-covalent complexes: An emerging technology
34. Hemoglobins from deep-sea hydrothermal vent scaleworms of the genus Branchipolynoe: A new type of quaternary structure
35. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a pep fide fragment from the β-domain
36. Direct measurement of islet amyloid polypeptide fibrillo-genesis by mass spectrometry
37. Identification of protein-protein interfaces by decreased amide proton solvent accessibility
38. Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry
39. Proposal for a common nomenclature for sequence ions in mass spectra of peptides
40. Primary structure differences of human surfactant-associated proteins isolated from normal and proteinosis lung
41. Pulmonary surfactant-associated polypeptide SP-C in lipid micelles: CD studies of intact SP-C and NMR secondary structure determination of depalmitoyl-SP-C(1-17)
42. Amyloid β-peptide polymerization studied using fluorescence correlation spectroscopy
43. On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants
44. Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR
45. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
46. High sensitivity collisionally-activated decomposition tandem mass spectrometry on a novel quadrupole/orthogonal-acceleration time-of- flight mass spectrometer
47. Synthetic peptide-containing surfactants - Evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to polyleucyl substitution
48. A method for S- and O-palmitoylation of peptides: Synthesis of pulmonary surfactant protein C models